Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 6, 2009, Pages 679-682

  Viegas, S ^a   Weir, A ^a   Esiri, M ^a   Kuker, W ^a   Waters, P ^a   Leite, M I ^a   Vincent, A ^a   Palace, J ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; AZATHIOPRINE; CITALOPRAM; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; PREDNISOLONE; RISPERIDONE; AQP4 PROTEIN, HUMAN; AUTOANTIBODY;

ADOLESCENT; ARTICLE; AUTOPSY; BEHAVIOR CHANGE; BRAIN BIOPSY; BRAIN STEM; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DRUG ERUPTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; IMMUNOSUPPRESSIVE TREATMENT; LEIGH DISEASE; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLASMAPHERESIS; PRIORITY JOURNAL; RADIODIAGNOSIS; STEREOTACTIC BIOPSY; SYMPTOMATOLOGY; TREATMENT OUTCOME; VOMITING; WEIGHT REDUCTION; BIOPSY; BRAIN THIRD VENTRICLE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FATALITY; HYPOTHALAMUS DISEASE; IMMUNOLOGY; NECROSIS; NEUROLOGIC EXAMINATION; OPTIC NERVE; PATHOLOGY; SPINAL CORD;

ADOLESCENT; AQUAPORIN 4; AUTOANTIBODIES; BIOPSY; BRAIN STEM; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; HUMANS; HYPOTHALAMIC DISEASES; HYPOTHALAMUS; MAGNETIC RESONANCE IMAGING; NECROSIS; NEUROLOGIC EXAMINATION; NEUROMYELITIS OPTICA; OPTIC NERVE; SPINAL CORD; THIRD VENTRICLE;

EID: 66149087329     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2008.157693     Document Type: Article

References (17)

1. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol 2007;6:805-815 (Pubitemid 47238676)
2. Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007;130:1194-1205 (Pubitemid 47355941)
3. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002;125:1450-1461 (Pubitemid 34755161)
4. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106-2112 (Pubitemid 39626806)
5. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005;202:473-477 (Pubitemid 41186945)
6. Waters P, Jarius S, Littleton E, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 2008;65:913-919 (Pubitemid 352008474)
7. Waters P, Vincent A. Detection of AQP-4 antibodies in NMO: current status of the assays. Int MS J. In press.
8. Wingerchuk DM, Hogancamp WF, O'Brien PC, et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107-1114 (Pubitemid 29442132)
9. Poppe AY, Lapierre Y, Melancon D, et al. Neuromyelitis optica with hypothalamic involvement. Mult Scler 2005;11:617-621 (Pubitemid 41387709)
10. Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006;63:390-396
11. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-1489 (Pubitemid 43958540)
12. Pittock SJ, Weinshenker BG, Lucchinetti CF, et al. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006;63:964-968 (Pubitemid 44036298)
13. Nozaki H, Shimohata T, Kanbayashi T, et al. A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions. Sleep Med. In press.
14. McKeon A, Lennon VA, Lotze T, et al. CNS aquaporin-4 autoimmunity in children. Neurology 2008;71:93-100.
15. Watanabe S, Nakashima I, Misu T, et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler 2007;13:128-132 (Pubitemid 46152772)
16. Wingerchuk DM, Weinshenker BG. Neuromyelitis optica. Curr Treat Options Neurol 2005;7:173-182 (Pubitemid 40894929)
17. Cree BA, Lamb S, Morgan K, et al. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 2005;64:1270-1272 (Pubitemid 40490534)